In this issue:
VTE risk in coeliac disease
Coffee protective for ESLD progression and after liver transplant
HBsAg and HBV DNA levels predict inactive carriers with low progression risk
1- vs. 2-week ligation intervals for oesophageal variceal bleeding
15-year gastric cancer risk in H. pylori infection
Mucosal healing and long-term UC outcomes
Rectal indomethacin reduces pancreatitis after ERCP
Swallowed fluticasone in paediatric eosinophilic oesophagitis
Vedolizumab for moderate-to-severe CD in the real-world
Recurrent bleeding and CV event risks with continued aspirin after lower GI bleed
Please login below to download this issue (PDF)